Coleen Glessner's Insider Trades & SAST Disclosures
Coleen Glessner's most recent trade in Emergent Biosolutions Inc was a trade of 480 Common Stock done at an average price of $4.4 . Disclosure was reported to the exchange on April 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Coleen Glessner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.44 per share. | 07 Apr 2025 | 480 | 176,176 (0%) | 0% | 4.4 | 2,131 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 249,613 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 176,656 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2025 | 24,078 | 114,469 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2025 | 5,913 | 138,547 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.48 per share. | 12 Feb 2025 | 313 | 114,156 (0%) | 0% | 7.5 | 2,341 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.01 per share. | 08 Dec 2024 | 18,674 | 144,460 (0%) | 0% | 9.0 | 168,253 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.19 per share. | 08 Jun 2024 | 1,249 | 163,134 (0%) | 0% | 6.2 | 7,731 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.29 per share. | 07 Apr 2024 | 585 | 164,383 (0%) | 0% | 2.3 | 1,340 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 125,000 | 187,113 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.39 per share. | 01 Mar 2024 | 381 | 164,968 (0%) | 0% | 3.4 | 1,292 | Common Stock |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 30,770 | 62,113 | - | - | Employee Stock Option (Right to buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 30,770 | 165,349 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 15,385 | 134,579 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Apr 2023 | 480 | 120,154 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 7,692 | 31,343 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 7,692 | 119,674 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 3,846 | 111,982 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 72,232 | 108,136 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 24,078 | 35,904 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 23,651 | 23,651 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 5,913 | 5,913 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Coleen Glessner | EVP, Quality & Ethics, and CPL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 5,913 | 11,826 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges